BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 8833323)

  • 1. Homogeneous enzyme-based binding assay for studying glycosaminoglycan interactions with macromolecules and peptides.
    Guo X; Han IS; Yang VC; Meyerhoff ME
    Anal Biochem; 1996 Mar; 235(2):153-60. PubMed ID: 8833323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pigment epithelium-derived factor (PEDF) binds to glycosaminoglycans: analysis of the binding site.
    Alberdi E; Hyde CC; Becerra SP
    Biochemistry; 1998 Jul; 37(30):10643-52. PubMed ID: 9692954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Raman spectroscopic investigation of peptide-glycosaminoglycan interactions.
    Ishwar AR; Jeong KJ; Panitch A; Akkus O
    Appl Spectrosc; 2009 Jun; 63(6):636-41. PubMed ID: 19531291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel method for evaluation of carbohydrate-binding activity: enzyme-linked carbohydrate-binding assay (ELCBA).
    Dolzhenko MI; Lepekhin EA; Berezin VA
    Biochem Mol Biol Int; 1994 Sep; 34(2):261-71. PubMed ID: 7849636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Xanthine oxidase binding to glycosaminoglycans: kinetics and superoxide dismutase interactions of immobilized xanthine oxidase-heparin complexes.
    Radi R; Rubbo H; Bush K; Freeman BA
    Arch Biochem Biophys; 1997 Mar; 339(1):125-35. PubMed ID: 9056242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Matrix localization of tissue factor pathway inhibitor-2/matrix-associated serine protease inhibitor (TFPI-2/MSPI) involves arginine-mediated ionic interactions with heparin and dermatan sulfate: heparin accelerates the activity of TFPI-2/MSPI toward plasmin.
    Liu Y; Stack SM; Lakka SS; Khan AJ; Woodley DT; Rao JS; Rao CN
    Arch Biochem Biophys; 1999 Oct; 370(1):112-8. PubMed ID: 10496984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycosaminoglycan-protein interactions: definition of consensus sites in glycosaminoglycan binding proteins.
    Hileman RE; Fromm JR; Weiler JM; Linhardt RJ
    Bioessays; 1998 Feb; 20(2):156-67. PubMed ID: 9631661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of glycosaminoglycans on cell proliferation of normal osteoblasts and human osteosarcoma cells depend on their type and fine chemical compositions.
    Nikitovic D; Zafiropoulos A; Tzanakakis GN; Karamanos NK; Tsatsakis AM
    Anticancer Res; 2005; 25(4):2851-6. PubMed ID: 16080537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding of interferon gamma by glycosaminoglycans: a strategy for localization and/or inhibition of its activity.
    Fernandez-Botran R; Yan J; Justus DE
    Cytokine; 1999 May; 11(5):313-25. PubMed ID: 10328871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pattern and spacing of basic amino acids in heparin binding sites.
    Fromm JR; Hileman RE; Caldwell EE; Weiler JM; Linhardt RJ
    Arch Biochem Biophys; 1997 Jul; 343(1):92-100. PubMed ID: 9210650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of osteoprotegerin binding to glycosaminoglycans by surface plasmon resonance: role in the interactions with receptor activator of nuclear factor kappaB ligand (RANKL) and RANK.
    Théoleyre S; Kwan Tat S; Vusio P; Blanchard F; Gallagher J; Ricard-Blum S; Fortun Y; Padrines M; Rédini F; Heymann D
    Biochem Biophys Res Commun; 2006 Aug; 347(2):460-7. PubMed ID: 16828054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carriers for enzymatic attachment of glycosaminoglycan chains to peptide.
    Takagaki K; Ishido K; Kakizaki I; Iwafune M; Endo M
    Biochem Biophys Res Commun; 2002 Apr; 293(1):220-4. PubMed ID: 12054587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The B16F10 cell receptor for a metastasis-promoting site on laminin-1 is a heparan sulfate/chondroitin sulfate-containing proteoglycan.
    Engbring JA; Hoffman MP; Karmand AJ; Kleinman HK
    Cancer Res; 2002 Jun; 62(12):3549-54. PubMed ID: 12068003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peptide-binding macromolecules in the blood of seriously ill or mentally retarded patients.
    Goodfriend TL; Sindel M; Fyhrquist F; Hong R; Azen E; Stewart JM
    J Lab Clin Med; 1976 Feb; 87(2):299-319. PubMed ID: 1455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specificities of heparin-binding sites from the amino-terminus and type 1 repeats of thrombospondin-1.
    Yu H; Tyrrell D; Cashel J; Guo NH; Vogel T; Sipes JM; Lam L; Fillit HM; Hartman J; Mendelovitz S; Panel A; Roberts DD
    Arch Biochem Biophys; 2000 Feb; 374(1):13-23. PubMed ID: 10640391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural insights into biological roles of protein-glycosaminoglycan interactions.
    Raman R; Sasisekharan V; Sasisekharan R
    Chem Biol; 2005 Mar; 12(3):267-77. PubMed ID: 15797210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Matrix glycosaminoglycans in the growth phase of fibroblasts: more of the story in wound healing.
    Kosir MA; Quinn CC; Wang W; Tromp G
    J Surg Res; 2000 Jul; 92(1):45-52. PubMed ID: 10864481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Iduronic acid-containing glycosaminoglycans on target cells are required for efficient respiratory syncytial virus infection.
    Hallak LK; Collins PL; Knudson W; Peeples ME
    Virology; 2000 Jun; 271(2):264-75. PubMed ID: 10860881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycosaminoglycans bind factor Xa in a Ca2+-dependent fashion and modulate its catalytic activity.
    O'Brien LA; Stafford AR; Fredenburgh JC; Weitz JI
    Biochemistry; 2003 Nov; 42(44):13091-8. PubMed ID: 14596625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and optimization of a binding assay for the XIAP BIR3 domain using fluorescence polarization.
    Nikolovska-Coleska Z; Wang R; Fang X; Pan H; Tomita Y; Li P; Roller PP; Krajewski K; Saito NG; Stuckey JA; Wang S
    Anal Biochem; 2004 Sep; 332(2):261-73. PubMed ID: 15325294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.